PMCCPMCCPMCC

Search tips
Search criteria 

Advanced

 
Logo of arthrestherBioMed Centralbiomed central web sitesearchsubmit a manuscriptregisterthis articleArthritis Research & Therapy
 
Arthritis Res Ther. 2011; 13(3): 221.
Published online 2011 May 31. doi:  10.1186/ar3324
PMCID: PMC3218875
Negative regulation of NF-κB and its involvement in rheumatoid arthritis
Geert van Loocorresponding author1,2 and Rudi Beyaertcorresponding author1,2
1Department for Molecular Biomedical Research, Unit of Molecular Signal Transduction in Inflammation, VIB, B-9052 Ghent, Belgium
2Department of Biomedical Molecular Biology, Ghent University, B-9052 Ghent, Belgium
corresponding authorCorresponding author.
Geert van Loo: geert.vanloo/at/dmbr.vib-ugent.be; Rudi Beyaert: rudi.beyaert/at/dmbr.vib-ugent.be
Abstract
The transcription factor NF-κB plays crucial roles in the regulation of inflammation and mmune responses, and inappropriate NF-κB activity has been linked with many autoimmune and inflammatory diseases, including rheumatoid arthritis. Cells employ a multilayered control system to keep NF-κB signalling in check, including a repertoire of negative feedback regulators ensuring termination of NF-κB responses. Here we will review various negative regulatory mechanisms that have evolved to control NF-κB signalling and which have been implicated in the pathogenesis of rheumatoid arthritis.
Articles from Arthritis Research & Therapy are provided here courtesy of
BioMed Central